Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
ImmuneOnco Biopharmaceuticals (Shanghai) (IOB HK)
Watchlist
8
Analysis
Health Care
•
China
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
14 Jan 2024 09:34
China Healthcare Weekly (Jan.12) - Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco
If we look at mainstream R&D trend, the choices made by companies like Innovent/BeiGene are reasonable. Investment value of Sirnaomics is low....
Xinyao (Criss) Wang
Follow
472 Views
Share
bullish
•
UBTech Robotics
•
18 Feb 2024 11:00
HSCI Index Rebalance: 25 Adds, 29 Deletes & Changes to Southbound Stock Connect
There are 25 adds and 29 deletes for the HSCI in March. 21 stocks will be added to Stock Connect while 27 will be deleted. Positions via the...
Brian Freitas
Follow
702 Views
Share
bullish
•
Shriram Finance
•
07 Jan 2024 05:10
Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
794 Views
Share
bullish
•
WuXi XDC Cayman
•
03 Jan 2024 05:00
HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March
There could be nearly 58 adds/deletes for the HSCI in September. That will trigger changes to the Southbound Stock Connect list and increase flows...
Brian Freitas
Follow
962 Views
Share
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
15 Aug 2023 08:55
Pre-IPO ImmuneOnco Biopharmaceuticals (PHIP Updates) - Slow Development Progress and Gloomy Outlook
ImmuneOnco's business model is self-development, leading to slow progress. Druggability/safety profile of CD47-targeted molecules are the biggest...
Xinyao (Criss) Wang
Follow
245 Views
Share
1
2
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x